Navigation Links
MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
Date:11/13/2007

se that reconciles historical Adjusted EBITDA to MedCath's income from continuing operations.

Management will discuss and answer questions regarding MedCath's quarterly results today during a 9 a.m. ET conference call. In the United States, you may participate by dialing (877) 697-5351. International callers should dial (706) 634-0602. The conference ID for both domestic and international callers is 22236624. A live web cast will also be available on the company's web site, http://www.medcath.com. This information will be available on the web site on or immediately following the conference call for 30 days. A recorded replay of the call will be available until 11:59 p.m. ET, November 20, 2007. To access the replay, domestic callers should dial (800) 642-1687 and international callers should dial (706) 645-9291. The archived conference ID is 22236624. This press release and the financial information included therewith will be accessible on the web, by going to http://www.medcath.com, "Investor Relations" then clicking on "News."

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns interests in and operates eleven hospitals with a total of 667 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. In addition, MedCath and its subsidiary MedCath Partners manage the cardiovascular program at various hospitals and provide services in diagnostic and therapeutic facilities in various states.

Parts of this announcement contain forward-looking statements that involve risks and uncertainties. Although management believes that these forward- looking statements are based on reasonable assumptions, these assumptions are inherently subject to s
'/>"/>

SOURCE MedCath Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2008)... Byetta has also been linked recently to patient d...s) -- A new once-a-week formulation of the injecta... better than the older twice-a-day formulation, re...ase of use, [the new formulation] provided the rem...cose control and good gastrointestinal tolerabilit...
(Date:9/5/2008)... HARRISBURG, Pa., Sept. 5 /PRNewswire-USNewswire/ ... issued a proclamation acknowledging Sept. 11 as,A...lth of Pennsylvania and The American Red Cross ask...oration of those who lost their,lives on 9/11 and ...lood,donation can save up to three lives., "We al...
(Date:9/5/2008)...earchers explain how theoretical ,anti-cloak, coul..., Sept. 5 (HealthDay News) -- Just in case someone...se scientists say they know how to uncloak the obj... in Optics Express , certain materials underneath...ts to be seen again. , Researchers at Shanghai ...
(Date:9/5/2008)... FRANKLIN, Mass., Sept. 5 /PRNewswire/ -- Arthrosu...developer of less-invasive joint,resurfacing syste...he U.S.,FDA to begin its pivotal investigation for...FDA stated that "there are no outstanding safety,c...tiation., Arthrosurface has been evaluating the s...
Breaking Medicine News(10 mins):Health News:Once-Weekly Diabetes Drug Boosts Blood Sugar Control 2Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2
...ge that victims of the terrible 'Elephant Man' cli... a 'reckless' rate.// The drug, a monoclonal anti...mia, multiple sclerosis and rheumatoid arthritis. ...t the victims had been injected 15 times faster th...
...lf of all children in the most rural counties of t...eas, according to a new study //by HHS Agency for ...published in the September-October 2006 issue of A... was led by AHRQ’s Frances Chevarley, Ph.D., analy...
...s can be treated with a low-priced antibiotic, acc...the limbs or scrotum. // A team of scientists at t...t doxycycline gave some relief to patients in the ...e. In addition, the antibiotic killed the causativ...
...earch has revealed that it is tougher to quit ment...be the reason for the excessive smoking-related di...lished in the Archives of Internal Medicine.Nearly...thol cigarettes like Kool or Newport in comparison...
Other Medicine News:Health News:Catastrophic Elephant Man Drug Trial Victims Injected Recklessly 2Health News:Local Health Care Limited for Rural Children 2Health News:Menthol cigarettes harder to quit than regular cigarettes 2
(Date:9/6/2008)...cent or Greater Concordance Compared to FISH ... - Company to Include Reporting for HER2 Gene Expr...eports by End of 2008 -, REDWOOD CITY, Calif., Se...c. (Nasdaq: GHDX ) today announced results from t...ng for HER2 gene expression, as measured by the,co...
(Date:9/5/2008)...PRNewswire-USNewswire/ -- The Florida,Technology, ...orida,Atlantic University researcher Dr. Herbert W...the Center for Molecular Biology and,Biotechnology... CHS,Resources LLC (CHS), $184,294 as part of the ...ance Grant program (SURECAG). SURECAG was,establis...
(Date:9/5/2008)..., Sept. 5 /- SARcode,Corpor... LFA-1 inhibitors,to treat inflammatory diseases, ...oday announced SARcode,s initiation of a Phase 1 c...ndidate for T-cell mediated ophthalmic,diseases. S...t providing,SARcode with an exclusive license to S...
(Date:9/4/2008)... 4 /- Cytopia Limited (ASX:,CYT) toda...s Phase Ib/II,study of CYT997, the company,s novel... with an aggressive form of brain cancer known as ...trial is the first Phase II efficacy study in high...ny and the second in its,suite of Phase II studies...
Breaking Medicine Technology:Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 2Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 3Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 5Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3Medgate Selected by NASA to Deliver Health and Safety Software Solutions 23181 1Back From the Dead 3A Cardiac Arrest Victim Salutes His Rescuer 23177 1Back From the Dead 3A Cardiac Arrest Victim Salutes His Rescuer 23177 2Georgia to Offer More Community Living Alternatives for Individuals With Disabilities 23174 1Georgia to Offer More Community Living Alternatives for Individuals With Disabilities 23174 2Georgia to Offer More Community Living Alternatives for Individuals With Disabilities 23174 3New Hope Against the Cold Sore Virus 23170 1New Hope Against the Cold Sore Virus 23170 2New Hope Against the Cold Sore Virus 23170 3
Transcranial vascular DWL doppler.
Transcranial vascular DWL doppler.
Transcranil vascular DWL doppler.
...m Viasys Neurocare is a full-featured physiologic ...table size. It contains many of the features of ou...t an economical price. , ,The smaller size of ...ironment, the physician's office, a mobile service...
Medicine Products: